» Articles » PMID: 22904064

Ablation of PRMT6 Reveals a Role As a Negative Transcriptional Regulator of the P53 Tumor Suppressor

Overview
Specialty Biochemistry
Date 2012 Aug 21
PMID 22904064
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Arginine methylation of histones is a well-known regulator of gene expression. Protein arginine methyltransferase 6 (PRMT6) has been shown to function as a transcriptional repressor by methylating the histone H3 arginine 2 [H3R2(me2a)] repressive mark; however, few targets are known. To define the physiological role of PRMT6 and to identify its targets, we generated PRMT6(-/-) mouse embryo fibroblasts (MEFs). We observed that early passage PRMT6(-/-) MEFs had growth defects and exhibited the hallmarks of cellular senescence. PRMT6(-/-) MEFs displayed high transcriptional levels of p53 and its targets, p21 and PML. Generation of PRMT6(-/-); p53(-/-) MEFs prevented the premature senescence, suggesting that the induction of senescence is p53-dependent. Using chromatin immunoprecipitation assays, we observed an enrichment of PRMT6 and H3R2(me2a) within the upstream region of Trp53. The PRMT6 association and the H3R2(me2a) mark were lost in PRMT6(-/-) MEFs and an increase in the H3K4(me3) activator mark was observed. Our findings define a new regulator of p53 transcriptional regulation and define a role for PRMT6 and arginine methylation in cellular senescence.

Citing Articles

Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells.

Eudenbach M, Busam J, Bouchard C, Rossbach O, Zarnack K, Bauer U Life Sci Alliance. 2025; 8(4).

PMID: 39900436 PMC: 11791029. DOI: 10.26508/lsa.202402946.


Protein arginine methyltransferase 6 is a novel substrate of protein arginine methyltransferase 1.

Cao M, Feng Y, Zheng Y World J Biol Chem. 2023; 14(5):84-98.

PMID: 37901302 PMC: 10600687. DOI: 10.4331/wjbc.v14.i5.84.


Critical Roles of Protein Arginine Methylation in the Central Nervous System.

Chang K, Gao D, Yan J, Lin L, Cui T, Lu S Mol Neurobiol. 2023; 60(10):6060-6091.

PMID: 37415067 DOI: 10.1007/s12035-023-03465-x.


Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review).

Wu K, Niu C, Liu H, Fu L Int J Oncol. 2023; 62(5).

PMID: 37026519 PMC: 10147102. DOI: 10.3892/ijo.2023.5510.


PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.

Shi Y, Niu Y, Yuan Y, Li K, Zhong C, Qiu Z Nat Commun. 2023; 14(1):1932.

PMID: 37024475 PMC: 10079833. DOI: 10.1038/s41467-023-37542-5.


References
1.
Lim Y, Lee E, Lee J, Oh S, Kim S . Down-regulation of asymmetric arginine methylation during replicative and H2O2-induced premature senescence in WI-38 human diploid fibroblasts. J Biochem. 2008; 144(4):523-9. DOI: 10.1093/jb/mvn097. View

2.
Ventura A, Kirsch D, McLaughlin M, Tuveson D, Grimm J, Lintault L . Restoration of p53 function leads to tumour regression in vivo. Nature. 2007; 445(7128):661-5. DOI: 10.1038/nature05541. View

3.
Serrano M, Lin A, McCurrach M, Beach D, Lowe S . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88(5):593-602. DOI: 10.1016/s0092-8674(00)81902-9. View

4.
Kirmizis A, Santos-Rosa H, Penkett C, Singer M, Vermeulen M, Mann M . Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature. 2007; 449(7164):928-32. PMC: 3350864. DOI: 10.1038/nature06160. View

5.
Noda A, Ning Y, Venable S, Smith J . Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res. 1994; 211(1):90-8. DOI: 10.1006/excr.1994.1063. View